En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor

. 2015 Dec ; 33 (12) : 1937-43. [epub] 20150425

Jazyk angličtina Země Německo Médium print-electronic

Typ dokumentu srovnávací studie, časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/pmid25910478
Odkazy

PubMed 25910478
DOI 10.1007/s00345-015-1568-6
PII: 10.1007/s00345-015-1568-6
Knihovny.cz E-zdroje

PURPOSE: En bloc resection of bladder tumors (ERBT) may improve staging quality and perioperative morbidity and influence tumor recurrence. This study was designed to evaluate the safety, efficacy, and recurrence rates of electrical versus laser en bloc resection of bladder tumors. METHODS: This European multicenter study included 221 patients at six academic hospitals. Transurethral ERBT was performed with monopolar/bipolar current or holmium/thulium laser energy. Staging quality measured by detrusor muscle involvement, various perioperative parameters, and 12-month follow-up data was analyzed. RESULTS: Electrical and laser ERBT were used to treat 156 and 65 patients, respectively. Median tumor size was 2.1 cm; largest tumor was 5 cm. Detrusor muscle was present in 97.3 %. A switch to conventional TURBT was significantly more frequent in the electrical ERBT group (26.3 vs. 1.5 %, p < 0.001). Median operation duration (25 min), postoperative irrigation (1 day), catheterization time (2 days), and hospitalization (3 days) were similar. Overall complication rate was low (Clavien ≥ 3, n = 6 [2.7 %]). Hemoglobin was significantly lower after electrical ERBT (p = 0.0013); however, overall hemoglobin loss was not clinically relevant (0.38 g/dl). Patients (n = 148) were followed for 12 months; 33 (22.3 %) had recurrences. In total, 63.6 % recurrences occurred outside the ERBT resection field. No difference was noted between ERBT groups. CONCLUSIONS: ERBT is safe and reliable regardless of the energy source and provides high-quality resections of tumors >1 cm. Recurrence rates did not differ between groups, and the majority of recurrences occurred outside the ERBT resection field.

Zobrazit více v PubMed

World J Urol. 2011 Aug;29(4):429-32 PubMed

Tech Urol. 1998 Mar;4(1):12-4 PubMed

J Urol. 2000 Mar;163(3):878-9 PubMed

Minim Invasive Ther Allied Technol. 2014 Aug;23(4):206-13 PubMed

Eur Urol. 2013 Oct;64(4):624-38 PubMed

World J Urol. 2015 Apr;33(4):581-2 PubMed

Urology. 2014 Apr;83(4):851-5 PubMed

World J Urol. 2015 Jul;33(7):997 PubMed

J Int Med Res. 2013 Aug;41(4):984-92 PubMed

BJU Int. 2015 Jan;115(1):14-23 PubMed

Urology. 2003 Dec;62(6):1089-91 PubMed

Indian J Urol. 2014 Apr;30(2):144-9 PubMed

World J Urol. 2010 Apr;28(2):157-61 PubMed

Eur Urol. 2013 Oct;64(4):639-53 PubMed

J Endourol. 2011 Oct;25(10):1599-603 PubMed

Eur Urol. 2012 Feb;61(2):317-25 PubMed

J Endourol. 2010 Jan;24(1):69-73 PubMed

Eur Urol. 2014 Aug;66(2):253-62 PubMed

Int J Urol. 2010 Aug;17(8):708-14 PubMed

CA Cancer J Clin. 2013 Jan;63(1):11-30 PubMed

J Urol. 2001 Dec;166(6):2148-50 PubMed

Urology. 2008 Sep;72(3):608-12 PubMed

Chin Med J (Engl). 2013;126(9):1761-5 PubMed

World J Urol. 2015 Apr;33(4):571-9 PubMed

World J Urol. 2011 Aug;29(4):423-7 PubMed

BJU Int. 2012 Mar;109(6):960-3 PubMed

Helv Chir Acta. 1978 Jul;45(3):307-11 PubMed

Eur J Surg Oncol. 2014 Jan;40(1):90-5 PubMed

World J Urol. 2009 Jun;27(3):295-300 PubMed

World J Urol. 2011 Aug;29(4):433-42 PubMed

Najít záznam

Citační ukazatele

Možnosti archivace